Industry Verticals »

All Categories

Insights »

About TMR »

Inhalation and Nasal Spray Generic Drugs Market

Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global inhalation and nasal spray generic drugs market for the historical period 2017–2018 and forecast period 2019–2027, increasing prevalence of asthma and COPD disorders, and burgeoning demand for cost-effective generic drugs are projected to drive the global inhalation and nasal spray generic drugs market during the forecast period
  • According to the report, the global inhalation and nasal spray generic drugs market was valued at US$ 27.5 Bn in 2018 and is anticipated to expand at a CAGR of 4.80% from 2019 to 2027
fa global inhalation nasal spray generic drugs marke

Rising prevalence of asthma and COPD Disorders: Key Drivers

  • Asthma and chronic obstructive pulmonary disease (COPD) are considered serious health problems. These affect a large proportion of the global population. Smoking, tobacco use, and air pollution are few of the risk factors associated with asthma and COPD. According to the American Lung Association, smoking is the primary risk factor for COPD and approximately 80% of COPD-related deaths are caused by smoking.
  • According to Global Burden of Disease Study 2015, asthma and COPD were the most prevalent chronic respiratory disease, affecting over 360 and 175 million people in 2015, respectively.
  • Prevalence of asthma and COPD is increasing in developed countries due to modernized lifestyle. On the other hand, air pollution and high rate of smoking have led to higher prevalence of serious respiratory diseases in developing countries.
  • Increase in the geriatric population suffering from COPD and asthma is also expected to accelerate the growth of the inhalation and nasal spray generic drugs market

Stringent Regulations for Generic Drugs to Hamper Market

  • With the availability of growing number of low-cost generic inhalation and nasal spray drugs across the globe, various regulatory bodies have opted for stringent norms in order to focus on quality. Regulators in developing regions such as Brazil, Mexico, and Russia have changed their regulatory guidelines pertaining to the sale of generic drugs. This change in regulation norms has led to considerable delays in approval processes, thereby launch of generic drugs in these markets
  • Furthermore, the new regulatory laws in Russia mandate clinical trials for generic products as well, thereby creating hurdles for various pharmaceutical companies operating in the region. Similarly, the Drugs Controller General of India, a domestic drug regulatory body, constituted several new drug advisory committees to oversee and check clinical trials, new drug approval processes, etc.
  • Therefore, stringent and strict regulatory norms put up by various developing countries would lead to sluggish growth of the inhalation and nasal spray generic drugs market.

Global Inhalation and nasal spray generic drugs Market: Competitive Landscape

  • This report profiles major players in the global inhalation and nasal spray generic drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global inhalation and nasal spray generic drugs market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global inhalation and nasal spray generic drugs market are
    • Allergan plc
    • Beximco Pharmaceuticals Ltd
    • Cipla Limited
    • Mylan N.V.
    • Nephron Pharmaceuticals Corporation
    • Sun Pharmaceutical Industries Ltd.
    • Hikma Pharmaceuticals PLC
    • Sandoz International GmbH (a Novartis Division)
    • Perrigo Company plc
    • Catalent Pharma Solutions
    • Teva Pharmaceutical Industries Ltd.

Global Inhalation and nasal spray generic drugs Market: Key Developments

Key players in the global inhalation and nasal spray generic drugs market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global inhalation and nasal spray generic drugs market. A few expansion strategies adopted by players operating in the global inhalation and nasal spray generic drugs market are:

  • In February 2020, Perrigo Company and Catalent Pharma Solutions announced the attainment of abbreviated new drug application (ANDA) approval from the U.S. FDA for the generic version of ProAir HFA. ProAir HFA is a medication for the treatment and prevention of reversible obstructive airway disease, and bronchospasm. 
  • In July 2015, Hikma Pharmaceuticals acquired Roxane Laboratories Inc. and Boehringer Ingelheim Roxane Inc., from Boehringer Ingelheim. Roxane was one of the leading U.S. specialty generics company. This acquisition enabled Hikma to strengthen its position in the U.S. generics market.

The report on the global inhalation and nasal spray generic drugs market discussed individual strategies, followed by company profiles of manufacturers of inhalation and nasal spray generic drugs. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global inhalation and nasal spray generic drugs market.

Frequently Asked Questions

What is the total market worth of inhalation and nasal spray generic drugs market?

Inhalation and nasal spray generic drugs market to be worth US$ 42,256.02 mn by 2027

What is the anticipated CAGR of the inhalation and nasal spray generic drugs market in the forecast period?

Inhalation and nasal spray generic drugs market is anticipated to expand at a CAGR of 4.80% from 2019 to 2027

What are the key driving factors for the growth of the inhalation and nasal spray generic drugs market?

Inhalation and nasal spray generic drugs market is driven by increasing prevalence of asthma and COPD disorders

Which is the rising prominent segment in the inhalation and nasal spray generic drugs market?

The asthma segment dominated the global inhalation and nasal spray generic drugs market and the trend is projected to continue during the forecast period

Who are the key players in the inhalation and nasal spray generic drugs market?

Key players in the global inhalation and nasal spray generic drugs market include Allergan plc, Beximco Pharmaceuticals Ltd, Cipla Limited, Mylan N.V., Nephron Pharmaceuticals Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Inhalation & Nasal Spray Generic Drugs Market

4. Market Overview

    4.1. Introduction

        4.1.1. Drug Class Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario, by Region/Globally

    5.2. Patient Pool Analysis, by Medical Indication

6. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, by Drug Class

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Inhalation & Nasal Spray Generic Drugs Market Value Forecast, by Drug Class, 2017–2027

        6.2.1. Corticosteroids

            6.2.1.1. Fluticasone

            6.2.1.2. Budesonide

            6.2.1.3. Beclomethasone

            6.2.1.4. Flunisolide

            6.2.1.5. Others

        6.2.2. Bronchodilators

            6.2.2.1. Albuterol

            6.2.2.2. Epinephrine

            6.2.2.3. Others

        6.2.3. Antihistamines

        6.2.4. Combinations

            6.2.4.1. Salmeterol/Fluticasone

            6.2.4.2. Formoterol/Budesonide

            6.2.4.3. Azelastine/Benzalkonium Chloride

            6.2.4.4. Others

        6.2.5. Decongestant Sprays

            6.2.5.1. Phenylephrine Hydrochloride

            6.2.5.2. Oxymetazoline Hydrochloride

    6.3. Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class

7. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, by Indication

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Inhalation & Nasal Spray Generic Drugs Market Value Forecast, by Indication, 2017–2027

        7.2.1. Asthma

        7.2.2. Chronic Obstructive Pulmonary Disease (COPD)

        7.2.3. Allergic Rhinitis

        7.2.4. Others

    7.3. Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication

8. Global Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Inhalation & Nasal Spray Generic Drugs Market Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Region

9. North America Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

        9.2.1. Corticosteroids

            9.2.1.1. Fluticasone

            9.2.1.2. Budesonide

            9.2.1.3. Beclomethasone

            9.2.1.4. Flunisolide

            9.2.1.5. Others

        9.2.2. Bronchodilators

            9.2.2.1. Albuterol

            9.2.2.2. Epinephrine

            9.2.2.3. Others

        9.2.3. Antihistamines

        9.2.4. Combinations

            9.2.4.1. Salmeterol/Fluticasone

            9.2.4.2. Formoterol/Budesonide

            9.2.4.3. Azelastine/Benzalkonium Chloride

            9.2.4.4. Others

        9.2.5. Decongestant Sprays

            9.2.5.1. Phenylephrine Hydrochloride

            9.2.5.2. Oxymetazoline Hydrochloride

    9.3. North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

        9.3.1. Asthma

        9.3.2. Chronic Obstructive Pulmonary Disease (COPD)

        9.3.3. Allergic Rhinitis

        9.3.4. Others

    9.4. North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

        9.5.1. By Drug Class

        9.5.2. By Indication

        9.5.3. By Country

10. Europe Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

        10.2.1. Corticosteroids

            10.2.1.1. Fluticasone

            10.2.1.2. Budesonide

            10.2.1.3. Beclomethasone

            10.2.1.4. Flunisolide

            10.2.1.5. Others

        10.2.2. Bronchodilators

            10.2.2.1. Albuterol

            10.2.2.2. Epinephrine

            10.2.2.3. Others

        10.2.3. Antihistamines

        10.2.4. Combinations

            10.2.4.1. Salmeterol/Fluticasone

            10.2.4.2. Formoterol/Budesonide

            10.2.4.3. Azelastine/Benzalkonium Chloride

            10.2.4.4. Others

        10.2.5. Decongestant Sprays

            10.2.5.1. Phenylephrine Hydrochloride

            10.2.5.2. Oxymetazoline Hydrochloride

    10.3. Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

        10.3.1. Asthma

        10.3.2. Chronic Obstructive Pulmonary Disease (COPD)

        10.3.3. Allergic Rhinitis

        10.3.4. Others

    10.4. Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

        10.4.1. U.K.

        10.4.2. Germany

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

        10.5.1. By Drug Class

        10.5.2. By Indication

        10.5.3. By Country/Sub-region

11. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

        11.2.1. Corticosteroids

            11.2.1.1. Fluticasone

            11.2.1.2. Budesonide

            11.2.1.3. Beclomethasone

            11.2.1.4. Flunisolide

            11.2.1.5. Others

        11.2.2. Bronchodilators

            11.2.2.1. Albuterol

            11.2.2.2. Epinephrine

            11.2.2.3. Others

        11.2.3. Antihistamines

        11.2.4. Combinations

            11.2.4.1. Salmeterol/Fluticasone

            11.2.4.2. Formoterol/Budesonide

            11.2.4.3. Azelastine/Benzalkonium Chloride

            11.2.4.4. Others

        11.2.5. Decongestant Sprays

            11.2.5.1. Phenylephrine Hydrochloride

            11.2.5.2. Oxymetazoline Hydrochloride

    11.3. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

        11.3.1. Asthma

        11.3.2. Chronic Obstructive Pulmonary Disease (COPD)

        11.3.3. Allergic Rhinitis

        11.3.4. Others

    11.4. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific 

    11.5. Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

        11.5.1. By Drug Class

        11.5.2. By Indication

        11.5.3. By Country/Sub-region

12. Latin America Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

        12.2.1. Corticosteroids

            12.2.1.1. Fluticasone

            12.2.1.2. Budesonide

            12.2.1.3. Beclomethasone

            12.2.1.4. Flunisolide

            12.2.1.5. Others

        12.2.2. Bronchodilators

            12.2.2.1. Albuterol

            12.2.2.2. Epinephrine

            12.2.2.3. Others

        12.2.3. Antihistamines

        12.2.4. Combinations

            12.2.4.1. Salmeterol/Fluticasone

            12.2.4.2. Formoterol/Budesonide

            12.2.4.3. Azelastine/Benzalkonium Chloride

            12.2.4.4. Others

        12.2.5. Decongestant Sprays

            12.2.5.1. Phenylephrine Hydrochloride

            12.2.5.2. Oxymetazoline Hydrochloride

    12.3. Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

        12.3.1. Asthma

        12.3.2. Chronic Obstructive Pulmonary Disease (COPD)

        12.3.3. Allergic Rhinitis

        12.3.4. Others

    12.4. Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

        12.4.1. Brazil 

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

        12.5.1. By Drug Class

        12.5.2. By Indication

        12.5.3. By Country/Sub-region

13. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

        13.2.1. Corticosteroids

            13.2.1.1. Fluticasone

            13.2.1.2. Budesonide

            13.2.1.3. Beclomethasone

            13.2.1.4. Flunisolide

            13.2.1.5. Others

        13.2.2. Bronchodilators

            13.2.2.1. Albuterol

            13.2.2.2. Epinephrine

            13.2.2.3. Others

        13.2.3. Antihistamines

        13.2.4. Combinations

            13.2.4.1. Salmeterol/Fluticasone

            13.2.4.2. Formoterol/Budesonide

            13.2.4.3. Azelastine/Benzalkonium Chloride

            13.2.4.4. Others

        13.2.5. Decongestant Sprays

            13.2.5.1. Phenylephrine Hydrochloride

            13.2.5.2. Oxymetazoline Hydrochloride

    13.3. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

        13.3.1. Asthma

        13.3.2. Chronic Obstructive Pulmonary Disease (COPD)

        13.3.3. Allergic Rhinitis

        13.3.4. Others

    13.4. Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa 

        13.4.3. Rest of Middle East & Africa

    13.5. North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness Analysis 

        13.5.1. By Drug Class

        13.5.2. By Indication

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by Tier and Size of companies)

    14.2. Market Share / Position Analysis, by Company, 2018

    14.3. Competitive Business Strategies

    14.4. Company Profiles

        14.4.1. Allergan plc.

            14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.1.2. Growth Strategies

            14.4.1.3. SWOT Analysis

        14.4.2. Beximco Pharmaceuticals Ltd 

            14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.2.2. Growth Strategies

            14.4.2.3. SWOT Analysis

        14.4.3. Cipla Limited

            14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.3.2. Growth Strategies

            14.4.3.3. SWOT Analysis

        14.4.4. Mylan N.V.

            14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.4.2. Growth Strategies

            14.4.4.3. SWOT Analysis

        14.4.5. Nephron Pharmaceuticals Corporation

            14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.5.2. Growth Strategies

            14.4.5.3. SWOT Analysis

        14.4.6. Sun Pharmaceutical Industries Ltd.

            14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.6.2. Growth Strategies

            14.4.6.3. SWOT Analysis 

        14.4.7. Hikma Pharmaceuticals PLC

            14.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.7.2. Growth Strategies

            14.4.7.3. SWOT Analysis

        14.4.8. Sandoz International GmbH (a Novartis Division)

            14.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.8.2. Growth Strategies

            14.4.8.3. SWOT Analysis

        14.4.9. Perrigo Company plc

            14.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.9.2. Growth Strategies

            14.4.9.3. SWOT Analysis

        14.4.10. Teva Pharmaceutical Industries Ltd.

            14.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.4.10.2. Growth Strategies

            14.4.10.3. SWOT Analysis

List of Table

Table 1 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 2 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 3 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

Table 4 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

Table 5 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

Table 6 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 7 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 8 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 9 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 10 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 11 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

Table 12 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

Table 13 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

Table 14 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 15 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 17 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 18 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

Table 19 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

Table 20 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

Table 21 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 22 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 24 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 25 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

Table 26 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

Table 27 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

Table 28 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 29 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 31 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 32 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

Table 33 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

Table 34 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

Table 35 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 36 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027

Table 38 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Corticosteroids, 2017–2027

Table 39 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Bronchodilators, 2017–2027

Table 40 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Combinations, 2017–2027

Table 41 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Decongestant Sprays, 2017–2027

Table 42 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2027

List of Figure

Figure 1 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 2 Global Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) and Forecast, 2019–2027

Figure 3 Global Inhalation & Nasal Spray Generic Drugs Market Value Share (%), by Drug Class, 2018

Figure 4 Global Inhalation & Nasal Spray Generic Drugs Market Value Share (%), by Indication, 2018

Figure 5 Global Inhalation & Nasal Spray Generic Drugs Market Value Share (%), by Region, 2018

Figure 6 Global Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 7 Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 8 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2017–2027

Figure 9 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bronchodilators, 2017–2027

Figure 10 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antihistamines, 2017–2027

Figure 11 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Combinations, 2017–2027

Figure 12 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Decongestant Sprays, 2017–2027

Figure 13 Global Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

Figure 14 Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Figure 15 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Asthma, 2017–2027

Figure 16 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by COPD, 2017–2027

Figure 17 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allergic Rhinits, 2017–2027

Figure 18 Global Inhalation & Nasal Spray Generic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 19 Global Inhalation & Nasal Spray Generic Drugs Market Value Share, by Region, 2018 and 2027 

Figure 20 Global Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Region, 2019–2027

Figure 21 North America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 22 North America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country, 2018 and 2027

Figure 23 North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country, 2019–2027

Figure 24 North America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 25 North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 26 North America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

Figure 27 North America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Figure 28 Europe Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 29 Europe Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 30 Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 31 Europe Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 32 Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 33 Europe Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

Figure 34 Europe Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Figure 35 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 36 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 37 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 38 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 39 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 40 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

Figure 41 Asia Pacific Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Figure 42 Latin America Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 43 Latin America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 44 Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 45 Latin America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 46 Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 47 Latin America Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

Figure 48 Latin America Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Figure 49 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 50 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 51 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 52 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 53 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Drug Class, 2019–2027

Figure 54 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Value Share Analysis, by Indication, 2018 and 2027

Figure 55 Middle East & Africa Inhalation & Nasal Spray Generic Drugs Market Attractiveness, by Indication, 2019–2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Inhalation and Nasal Spray Generic Drugs Market

Schedule a Call